Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19

LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

Saved in:

Bibliographic Details
Published in:	Aliment Pharmacol Ther
Main Authors:	Prentice, Ralley E., Tjandra, Doug, Garg, Mayur, Lubel, John S., Fourlanos, Spiros, Johnson, Doug, Al‐Ani, Aysha, Christensen, Britt
Format:	Artigo
Language:	Inglês
Published:	John Wiley and Sons Inc. 2020
Subjects:	Letters to the Editors
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7537250/ https://ncbi.nlm.nih.gov/pubmed/33105980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.16063
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items